Clinical Trials Browser

Withdrawn × Biopsy × Breast × Clear all

NCT06590558 2025-07-03

Testing the Addition of an Investigational Anti-Cancer Drug, ASTX660 (Tolinapant), to a Usual Chemotherapy Treatment (Eribulin) for Treatment of Advanced Triple Negative Breast Cancer

Phase 1 Withdrawn

Triple Negative Breast Neoplasms

NCT05967286 2024-03-20

Olaparib and Alpelisib for Treatment of Metastatic Breast Cancer, A ComboMATCH Treatment Trial

Phase 2 Withdrawn

Anatomic Stage III Breast Cancer AJCC v8

NCT05238831 2024-01-23

SMMART Adaptive Clinical Treatment (ACT) Trial

Phase EARLY_PHASE1 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicSarcoma

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma

NCT05244434 2022-06-09

Effects of Ribociclib and Palbociclib on Tumor and Blood Characteristics in Patients With Metastatic Breast Cancer

Phase NA Withdrawn

Advanced Breast Adenocarcinoma

NCT02817607 2019-05-07

Study to Assess Breast Sensation Before and After Breast Cancer Treatment

Phase NA Withdrawn

Carcinoma, Intraductal, Noninfiltrating

NCT02610920 2019-03-26

Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast

NCT01409226 2012-04-05

3.0 Tesla Magnetic Resonance Imaging for Breast Cancer Detection in High Risk Women

Phase NA Withdrawn

Breast Neoplasms, Disease